Orofacial dyskinesia induced by nasal Ritalin® (methylphenidate) sniffing: A rare case report from Switzerland

Human and Experimental Toxicology

Volumn 32, Issue 3, 2013, Pages 332-334

  Marti, G ^a   Fattinger, K ^a   Zimmermann, H ^a   Exadaktylos, A ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

dyskinesia; intoxication; Methylphenidate; orofacial; Ritalin ; sniffing

Indexed keywords

LORAZEPAM; METHYLPHENIDATE;

ADULT; ARTICLE; ATTENTION DEFICIT DISORDER; CASE REPORT; HUMAN; LABORATORY TEST; MALE; NEUROLOGIC EXAMINATION; OROFACIAL DYSKINESIA; PHYSICAL EXAMINATION; PRESCRIPTION; PRIORITY JOURNAL;

ADMINISTRATION, INTRANASAL; ADULT; CENTRAL NERVOUS SYSTEM STIMULANTS; HUMANS; HYPNOTICS AND SEDATIVES; LORAZEPAM; MALE; METHYLPHENIDATE; MOVEMENT DISORDERS; SWITZERLAND; YOUNG ADULT;

EID: 84875275929     PISSN: 09603271     EISSN: 14770903     Source Type: Journal    
DOI: 10.1177/0960327112467044     Document Type: Article

References (15)

1. Kimko HC, Coss JT, Abernethy DR. Pharmacokinetics and clinical effectiveness of methylphenidate. Clin Pharmacokinet. 1999 ; 37: 457-470
2. Fern D, Jarman F, Barker M. Side effects of methylphenidate and dexamphetamine in children with attention deficit hyperactivity disorder: a double blind, crossover trial. Pediatrics. 1997 ; 100: 662-666
3. Solanto MV. Neuropsychopharmacological mechanisms of stimulant drug action in attention-deficit hyperactivity disorder: a review and integration. Behav Brain Res. 1998 ; 94: 127-152
4. Rosenberg D, Holttum J, Gershon S Textbook of pharmacotherapy for child and adolescent psychiatric disorders: antipsychotic agents. New York, NY: Brunner/Mazel ; 1994: 211-216.
5. Rush CR, Baker RW. Behavioral pharmacological similarities between methylphenidate and cocaine in cocaine abusers. Exp Clin Psychopharmacol. 2001 ; 9: 59-73
6. Sevak RJ, Stoops WW, Hays LR, Rush CR. Discriminative stimulus and subject-rated effects of methamphetamine, d-amphetamine, methylphenidate, and triazolam in methamphetamine-trained humans. J Pharmacol Exp Ther. 2009 ; 328: 1007-1018
7. Arria AM, Caldeira KM, O'Grady KE, Vincent KB, Johnson EP, Wish ED. Nonmedical use of prescription stimulants among college students: associations with attention-deficit-hyperactivity disorder and polydrug use. Pharmacotherapy. 2008 ; 28: 156-169
8. Bruggisser M, Bodmer M, Liechti ME. Severe toxicity due to injected but not oral or nasal abuse of methylphenidate tablets. Swiss Med Wkly. 2011 ; 141: w13267
9. Balazs J, Besnyo M, Gadaros J. Methylphenidate-induced orofacial and extremity dyskinesia. J Child Adol Psychopharmacol. 2007 ; 17: 378-391
10. Hollis CP, Thompson A. Acute dyskinesia on starting methylphenidate after risperidone withdrawal. Pediatr Neurol. 2007 ; 37: 287-288
11. Mattson RH, Calverley JR. Dextroamphetamine-sulfate-induced dyskinesias. JAMA. 1968 ; 204: 400-402
12. Case Q, McAndrew JB Clin Pediatr (Phila). 1974: 69.
13. Senecky Y, Lobel D, Diamond GW, Weitz GW, Inbar D. Isolated orofacial dyskinesia: a methylphenidate-induced movement disorder. Pediatr Neurol. 2002 ; 27: 224-226
14. Heinrich TW. A case report of methylphenidate-induced dyskinesia. Prim Care Companion J Clin Psychiatry. 2002 ; 4: 158-159
15. Koehm M, Kauert G, Toennes S. Influence of ethanol on the pharmacokinetics of methylphenidates metabolites ritalinic acid and ethylphenidate. Arzneimittelforschung. 2010 ; 60 (5). 238-244